Recent news on Reopro

Premier Introduces New Tools for Managing Pharmacy Performance ...  -  Apr 30, 2007
dBusinessNews Charlotte (press release),Starting April 30, 2007, participating members can more effectively manage the performance programs from seven more drug companies, including ReoPro ® from

The Moose in the Room  -  Apr 16, 2007
Scientist,A significant part of this job was maintaining a strategic alliance with the then-independent Centocor to market the antithrombotic drug, ReoPro (abciximab)

Stony Brook ranks high  -  Feb 22, 2007
Long Island Business News (subscription),Among the inventions and products developed at Stony Brook that contributed to its licensing revenue for 2005 are ReoPro, the first drug ever developed by a

Medicure Announces Second Quarter Fiscal 2007 Financial Results  -  Jan 12, 2007
Genetic Engineering News (press release),The Company announced that new data comparing Single High-Dose Bolus AGGRASTAT(R) (tirofiban) versus ReoPro(R) (abciximab) in patients undergoing

Medicure Announces Second Quarter Fiscal 2007 Financial Results  -  Jan 12, 2007
Market Wire (press release)The Company announced that new data comparing Single High-Dose Bolus AGGRASTAT® (tirofiban) versus ReoPro® (abciximab) in patients undergoing percutaneous

Affimed´s Fully Human Anti Thrombosis Antibody Shows in Vivo ...  -  Dec 4, 2006
PharmaLive.com (press release),The current antibody on the market for thrombosis is Reopro, a chimeric antibody that does not distinguish between the activated and non-activated forms of

Abciximab Helpful in Thrombosis During Intracranial Aneurysm ...  -  Dec 4, 2006
DG NewsCHICAGO, IL -- December 4, 2006 -- The glycoprotein IIb/IIIA platelet activation inhibitor abciximab (ReoPro) appears successful in stopping thrombosis in

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional